Copy
View this email in your browser
Share Share
Tweet Tweet
Forward Forward

Update for Primary Care

Our latest primary care news and guidance.
 
February 2021
News | Clinical knowledge summaries | Into practice | Events | Get involved

News

NICE to launch new 5-year strategy

Our new strategic plan will set out how we’ll be more dynamic and responsive in our work. Find out what this means for you at our virtual launch event on Monday 19 April 2021.

Register to attend launch event
A person's pregnant belly held with both hands

Treatment options for severe pregnancy sickness recommended in draft guidance

Pharmacological antiemetics, acupressure and intravenous fluids have been recommended to treat extreme cases of nausea and vomiting in pregnancy.

Our draft guidance is open for consultation until Wednesday 24 March.

Catch up on all our latest news articles
NICE Talks logo

How does NICE work with patients and patient groups?

In this episode, we look at how our Public Involvement Programme works and discover what it's like to be a patient representative on a committee. We talk to Laura Norburn, senior operations manager for NICE's Public Involvement Programme and Jo Jerrome, chief executive of Thrombosis UK.

Presenting a case for change: reviewing our processes for health technology evaluation

We are consultating on proposals to change the processes we use for the evaluation of medicines, medical devices, diagnostics and digital health technologies.

The proposals explore opportunities for:

  • aligning the current guidance programme processes
  • new process improvements and ways of working
  • improving the commercial and managed access processes
  • making the criteria for selecting topics for evaluation through NICE’s Highly Specialised Technologies Programme clearer.

The consultation is open until Tuesday 15 April 2021.

We are also holding a consultation event. Join this online session to learn more about the proposals: 

  • Thursday 25 February 2021, 4pm to 5pm. 
Comment on NICE's process review consultation

Assessing the resource impact of NICE guidance: process manual updated

We've updated our assessing resource impact process manual, making it clearer and easier to use. The manual describes the processes we follow to estimate the resource impact of NICE guidance.
 
We've:

  • Streamlined the manual into a single document. Previously, we had 2 separate manuals: one for guidelines and one for health technology assessments and highly specialised technologies.
  • Included new information on the processes for assessing resource impact for medical and diagnostic technologies.
  • Updated the presentation of the resource impact assessment tools to better meet user needs.

Clinical knowledge summaries

We've recently updated the following clinical knowledge summary (CKS) topics:

  • Mental health in students. New CKS topic. We’ve reviewed the evidence base in detail, and clearly justified and transparently linked recommendations to the supporting evidence.
  • Diabetes type 2. Minor restructuring to improve clarity and navigation. We’ve added information on the hyperglycaemic emergency complication of hyperosmolar hyperglycaemic state. We’ve updated the recommendations in line with current literature.
  • Tennis elbow. Minor structural changes and we’ve added a recommendation not to use corticosteroids routinely for treating tennis elbow.
  • We’ve updated contraindications and drug interactions for erythromycin in prescribing sections of multiple topics in line with a Medicines and Healthcare products Regulatory Agency drug safety update.
Our CKS provide primary care practitioners with a readily accessible summary of the evidence base and best practice guidance for over 370 topics. These cover 1,000 clinical presentations or patient scenarios, free to access in the UK.

Into practice

The generic NICE impact cover of the series of reports

New impact report on cardiovascular disease (CVD) management

Our latest impact report considers how evidence-based guidance has contributed to improvements in the care of people with CVD. Judith Richardson, NICE’s acting director for health and social care, has written a blog about the report in the National Health Executive.

NICE impact reports look at how implementation of our evidence-based guidance is improving health and wellbeing.

 View CVD management impact report

Events

NICE public board meeting

Our next public board meeting provides an opportunity to hear from our board and executive team. They’ll be sharing the latest updates about our work and will take your questions.
 
Our next meeting is scheduled:

  • Wednesday 24 March 2021, 1:30pm to 4:00pm, through Zoom.
Register to attend our virtual public board meeting

Get involved

What would you like to know more about?

To help us tailor our communications to meet your needs, we'd like to know which aspects of NICE's work you'd like to hear more about. Complete a short survey to share your views.

Answer 3 quick questions

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
 
See all our open consultations

Join a committee

We’re looking for GPs and nurses to join 3 committees:

See all our committee vacancies

Observe a meeting

Due to the coronavirus pandemic, we're currently holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Monday 15 and Tuesday 16 March 2021 – Public health advisory committee E
    Reducing sexually transmitted infections
    Registration closes Monday 1 March 2021.
    Agenda and register here
  • Monday 22 and Tuesday 23 March 2021 – Public health advisory committee B
    Mental wellbeing at work
    Registration closes Monday 8 March 2021.
    Agenda and register here
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
 
See all our public meetings
Instagram
Instagram
Facebook
Facebook
Twitter
Twitter
SoundCloud
SoundCloud
YouTube
YouTube
LinkedIn
LinkedIn

unsubscribe from this list